Publications by authors named "Andre Diessner"

Claim this Profile
I
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant.
Gwenn Waerlop, Yorick Janssens, Bart Jacobs, Franziska Jarczowski, André Diessner

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine.
Isabel Leroux-Roels, Cathy Maes, Jasper Joye, Bart Jacobs, Franziska Jarczowski, André Diessner

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plants.
Daniel Tusé, Maria Malm, Kirsi Tamminen, André Diessner, Frank Thieme

Vaccine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in .
Maria Malm, André Diessner, Kirsi Tamminen, Markus Liebscher, Timo Vesikari

Pharmaceutics· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protein-free IANUS peptide array uncovers interaction sites between Escherichia coli parvulin 10 and alkyl hydroperoxide reductase.
Miroslav Malesević, Angela Poehlmann, Birte Hernandez Alvarez, André Diessner, Mario Träger

Biochemistry· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis